Reassdrtant virus results < Reassortant < Reassortant clone

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Reassortant

Number of relevant bibliographic references: 68.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000B12 (2012)	Lanying Du [États-Unis] ; Ye Li [États-Unis, République populaire de Chine] ; Jimin Gao [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Shibo Jiang [États-Unis, République populaire de Chine]	Potential strategies and biosafety protocols used for dual‐use research on highly pathogenic influenza viruses
000B14 (2012)	Andrzej Kowalczyk [Pologne] ; Kinga Urbaniak [Pologne] ; Iwona Markowska-Daniel [Pologne]	Phylogenetic Analysis of the First Isolate of Polish H1N2 Swine Influenza Virus
000D46 (2011)	Karen Ka Yin Wong [Australie] ; Rowena A. Bull [Australie] ; Steve Rockman [Australie] ; Gillian Scott [Australie] ; Sacha Stelzer-Braid [Australie] ; William Rawlinson [Australie]	Correlation of polymerase replication fidelity with genetic evolution of influenza A/Fujian/411/02(H3N2) viruses
001724 (2003)	Susan J. Baigent [Royaume-Uni] ; John W. Mccauley [Royaume-Uni]	Influenza type A in humans, mammals and birds: Determinants of virus virulence, host‐range and interspecies transmission
001827 (2001)	A. I. Klimov [États-Unis] ; I. V. Kiseleva [Russie] ; J. A. Desheva [Russie] ; G. I. Alexandrova [Russie] ; N. J. Cox [États-Unis] ; L. G. Rudenko [Russie]	Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age
001836 (2001)	Masato Hatta [États-Unis] ; Peter Halfmann [États-Unis] ; Krisna Wells [États-Unis] ; Yoshihiro Kawaoka [Japon, États-Unis]	Genetic incompatibility among influenza A viruses
001837 (2001)	A. I Klimov [États-Unis] ; I. V Kiseleva [Russie] ; G. I Alexandrova [Russie] ; N. J Cox [États-Unis]	Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus
001868 (2001)	M. D Wareing [Australie] ; G. A Tannock [Australie]	Live attenuated vaccines against influenza; an historical review
001870 (2001)	Guus F. Rimmelzwaan [Pays-Bas] ; Albert D. M. E Osterhaus [Pays-Bas]	Influenza vaccines: new developments
001872 (2001)	M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie]	Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice
001885 (2001)	Michael Pfleiderer [Allemagne] ; Johannes Löwer [Allemagne] ; Reinhard Kurth [Allemagne]	Cold-attenuated live influenza vaccines, a risk-benefit assessment
001914 (2000)	Larisa G. Rudenko [Russie] ; Nancy H. Arden [États-Unis] ; Elena Grigorieva [Russie] ; Anatoli Naychin [Russie] ; Andrei Rekstin [Russie] ; Alexander I. Klimov [États-Unis] ; Svetlana Donina [Russie] ; Julia Desheva [Russie] ; Robert C. Holman [États-Unis] ; Angel Deguzman [Russie] ; Nancy J. Cox [États-Unis] ; Jacqueline M. Katz [États-Unis]	Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents
001945 (2000)	Toshihiro Ito [Japon]	Interspecies Transmission and Receptor Recognition of Influenza A Viruses
001954 (2000)	Nan Nan Zhou [États-Unis] ; Dennis A. Senne [États-Unis] ; John S. Landgraf [États-Unis] ; Sabrina L. Swenson [États-Unis] ; Gene Erickson [États-Unis] ; Kurt Rossow [États-Unis] ; Lin Liu [États-Unis] ; Kyoung-Jin Yoon [États-Unis] ; Scott Krauss [États-Unis] ; Robert G. Webster [États-Unis]	Emergence of H3N2 reassortant influenza A viruses in North American pigs
001995 (1999)	Kennedy F. Shortridge [République populaire de Chine, Hong Kong]	Influenzaa continuing detective story
001A09 (1999)	Hunein F. Maassab [États-Unis] ; Martin L. Bryant [États-Unis]	The development of live attenuated cold‐adapted influenza virus vaccine for humans
001A16 (1999)	David A. Steinhauer [Royaume-Uni]	Role of Hemagglutinin Cleavage for the Pathogenicity of Influenza Virus
001A27 (1999)	Masanori Terajima ; Julie Jameson ; Joyce E. Norman ; John Cruz ; Francis A. Ennis	High-Yield Reassortant Influenza Vaccine Production Virus Has a Mutation at an HLA-A 2.1-Restricted CD8+ CTL Epitope on the NS1 Protein
001B06 (1998)	Michael W. Shaw [États-Unis] ; Irina V. Kiseleva [Russie] ; Andrei Y. Egorov [Russie] ; Mark L. Hemphill [États-Unis] ; Xiyan Xu [États-Unis]	Generation of influenza transfectants using purified recombinant nucleocapsid protein
001B37 (1997)	Julia R. Romanova [Russie] ; Gregory A. Tannock [Australie] ; Galina I. Alexandrova [Russie]	Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses
001B55 (1997)	Brian R. Murphy [États-Unis] ; Eun Ju Park [États-Unis] ; Paul Gottlieb [États-Unis] ; Kanta Subbarao [États-Unis]	An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Reassortant" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Reassortant" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Reassortant
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021